PRE CLINICAL TRIAL

  1. The Reduction of Aorta Histopathological Images Through Inhibition of Reactive Oxygen Species Formation in Hypercholesterolemia Rattus novergicus Treated with Polysaccharide Peptide on Ganoderma lucidum (2014)
  2. Anti Inflammation and Anti Oxidant Effect of Active Agent Polysaccharide Peptide (Ganoderma lucidum) in Preventing Atherosclerotic Disease (2015)
  3. Polysaccharide Peptide: A Promising Anti Inflammation and Anti Oxidant in Atherosclerosis (2015)
  4. Polysaccharide Peptide: A Novel Anti-Inflammation in Reducing Intima Media Proliferation in Diabetic Rats (2015)
  5. Reducing of Histopathological Images Through a Decrease in H 2 O 2 Levels in Diabetic Rats with Polysaccharide Peptides (2015)
  6. The Inhibitory Effects of Polysaccharide Peptide (PsP) of Ganoderma lucidum Against Atherosclerosis in Rats with Dyslipidemia (2017)

TOXICOLOGY TRIAL

  1. Subchronic Toxicity of Ganoderma lucidum Polysaccharide Peptide (PsP) to Liver Physiology and Histopathology Imaging of Liver on Rattus norvegicus strain Wistar Rats (2014)
  2. Effect of Subchronic Exposure of PsP Ganoderma lucidum on Renal Function and Histopathology Feature in Rattus novergicus Wistar Strain (2015)
  3. Evaluation Subchronic Toxic Effect of Polysaccharide Peptide on Lipid and Hematologic Profile in Rattus norvegicus strain Wistar (2016)

 CLINICAL TRIAL

  1. The Role of Polysaccharide Peptide of Ganoderma lucidum as a Potent Antioxidant Against Atherosclerosis in High Risk and Stable Angina Patients (2017)